The Brainomix automated e-ILD CT algorithm outperforms forced vital capacity in predicting outcomes for patients with idiopathic pulmonary fibrosis

From a baseline CT scan, e-ILD automated biomarkers predict FVC decline and survival in IPF patients outperforming change in FVC. Exploratory clinical trial endpoints combining automated imaging biomarkers with FVC may improve patient selection and definition of treatment response.